Black Peptide
Retatrutide 40mg/3ml | Dual-Chamber Pen
Retatrutide 40mg/3ml | Dual-Chamber Pen
Couldn't load pickup availability
What is Retatrutide?
Retatrutide is a new-generation experimental peptide developed to act on key mechanisms regulating energy balance and metabolism. It is a so-called triple agonist, simultaneously activating GLP-1, GIP, and glucagon receptors – a combination aimed at both appetite control and increased energy expenditure. Through this multidirectional action, Retatrutide influences central hunger regulation, peripheral metabolism, and nutrient substrate processing, which distinguishes it from previous generations of incretin agonists.
What are the potential benefits of Retatrutide?
The potential benefits of Retatrutide are associated with its complex effect on appetite, glucose metabolism, and energy expenditure:
- Appetite control – supports the reduction of hunger through central satiety mechanisms.
- Influence on energy expenditure – activation of the glucagon receptor contributes to increased metabolic activity.
- Support for significant body weight reduction – through the combined influence on energy intake and expenditure.
- Optimization of glucose metabolism – supports more stable glycemic control.
- Overall improvement of the metabolic profile – with a potential positive impact on body composition and insulin sensitivity.
How to dose Retatrutide with a Dual-Chamber Pen?
Dosage and concentration for Retatrutide 6mg/1ml:
- 1 unit = 60 mcg Retatrutide
- Total content: 100 units (6 mg) in a Dual-Chamber pen
Recommended dosage levels for 6mg/1ml:
- Initial dose: 33.5 units (2 mg)
- Medium dose: 66.5 units (4 mg)
- Increased dose: 100 units (6 mg)
Dosage and concentration for Retatrutide 12mg/1ml:
- 1 unit = 120 mcg Retatrutide
- Total content: 100 units (12 mg) in a Dual-Chamber pen
Recommended dosage levels for 12mg/1ml:
- Initial dose: 16.5 units (2 mg)
- Medium dose: 33.5 units (4 mg)
- Increased dose: 50 units (6 mg)
Administration once a week is recommended. The duration may vary depending on the protocol, user's age, and study objectives. A break between cycles is recommended.
Share
